MECOM and ovarian cancer: While gene amplification was proposed as a potential mechanism for EVI1 overexpression in ovarian cancer [12,27], activation of EVI1-associated distal enhancers was correlated with increased EVI1 expression in pancreatic ductal adenocarcinoma, and JQ1 reduced EVI1 expression in the corresponding organoids [11].